# ZADEC ApS

**CVR:** 29312206
**Status:** active
**Company type:** Anpartsselskab
**Founded:** 2006-01-23
**Industry:** 721000 — Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
**Address:** c/o MC2 Therapeutics A/S, Agern Alle 24, 2970 Hørsholm
**Capital:** 500,021 DKK

> **Pro tier:** CDS credit-health score (0–100) for this company is available on Pro. Upgrade: https://companydata.dk/priser

## Financials


| Year | Revenue | Profit | Equity | Assets | Employees |

|------|---------|--------|--------|--------|-----------|

| 2025 | — | -377,192 DKK | -2,708,317 DKK | 449,214 DKK | 0 |

> **Pro tier:** 13 additional years of financial statements (2012–2024) available on Pro — including full revenue, profit, equity, and assets per year. Upgrade: https://companydata.dk/priser

## Owners (2)


- **MC2 Therapeutics A/S** — CVR 29526346 — VIRKSOMHED — 0.90% ownership — since 2011-01-01
- **FEY HOLDING ApS** — CVR 29530777 — VIRKSOMHED — 0.05% ownership — since 2011-01-01

## Executive management (4)


- **Anette Merete Nøhr Clausen** — DIREKTØR — since 2006-09-19
- **Jesper Jørn Lange** — DIREKTØR — since 2006-11-30
- **Steen Sindet-Pedersen** — DIREKTØR — since 2006-01-23
- **Trine Ahlgreen** — DIREKTØR — since 2025-05-27

## Secondary names

- ZADEC HOLDING ApS
- DrugMode ApS
- DrugMap ApS
- Pride Proteomics ApS

---
*Free-tier view. Pro subscribers additionally see: 13 additional years of financial statements (2012–2024) available on Pro — including full revenue, profit, equity, and assets per year. CDS credit-health score (0–100) for this company is available on Pro. See https://companydata.dk/priser*

Source: Danish public registries (CVR / Ejendomsvurderingen). Canonical: https://companydata.dk/da/virksomhed/29312206-zadec-aps